News >

Prostate Cancer Treatment Options Expand With ADT Combinations

Ellie Leick
Published: Wednesday, Dec 04, 2019

David F. Penson, MD, MPH, MMHC, the chair of the Department of Urology and the Paul V. Hamilton, MD and Virginia E. Howd Chair of Urologic Oncology at Vanderbilt University Medical Center

David F. Penson, MD, MPH, MMHC

Treatment for prostate cancer has evolved over the past few years to include androgen deprivation therapy (ADT) combined with other agents, such as next-generation androgen receptors, explained David F. Penson, MD, MPH, MMHC.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication